Rituximab-CHOP induced interstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma
- Authors
- Kim, Kwang Min; Kim, Ho-Cheol; Jeon, Kyung-Nyeo; Kim, Hoon-Gu; Kang, Jung Hun; Hahm, Jong Ryeal; Lee, Gyeong-Won
- Issue Date
- Feb-2008
- Publisher
- 연세대학교의과대학
- Keywords
- interstitial pneumonitis; rituximab; lymphoma
- Citation
- Yonsei Medical Journal, v.49, no.1, pp 155 - 158
- Pages
- 4
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- Yonsei Medical Journal
- Volume
- 49
- Number
- 1
- Start Page
- 155
- End Page
- 158
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/27486
- DOI
- 10.3349/ymj.2008.49.1.155
- ISSN
- 0513-5796
1976-2437
- Abstract
- A 69-year-old male was diagnosed in February 2004 with stage IV extranodal marginal zone B cell lymphoma involving the mediastinal nodes, lung parenchyma and bone marrow with high LDH. Shortness of breath developed following the 5th course of Rituximab-CHOP chemotherapy (cyclophosphamide, Vincristine, Doxorubicin, Prednisolone). Bronchoscopy guided transbronchial lung biopsy revealed interstitial thickening and type II pneumocyte activation, compatible with interstitial pneumonitis. After treatment with prednisolone a complete resolution of the dyspnea was observed. The patient was well on routine follow-up at the outpatient clinic, with no progression of lymphoma or interstitial pneumonitis.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
- 의학계열 > 의학과 > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.